Table 3 Comparison of immunophenotype of papillary renal neoplasm with reverse polarity with type I and type II papillary renal cell carcinoma
PRNRP (n = 11) | type I PRCC (n = 16) | type II PRCC (n = 9) | PRNRP vs type I PRCC | PRNRP vs type II PRCC | type I PRCC vs type II PRCC | |
|---|---|---|---|---|---|---|
Vimentin | 0/11 | 16/16 | 7/9 | < 0.001 | < 0.001 | 0.120 |
EMA | 11/11 | 13/16 | 7/9 | 0.248 | 0.190 | 1.000 |
CK7 | 11/11 | 12/16 | 4/9 | 0.123 | 0.008 | 0.200 |
CD10 | 1/11 | 7/16 | 8/9 | 0.090 | < 0.001 | 0.041 |
CA9 | 0/11 | 0/16 | 1/9 | 1.000 | 0.450 | 0.360 |
P504S | 4/11 | 15/16 | 9/9 | 0.003 | 0.005 | 1.000 |
RCC | 0/11 | 13/16 | 6/9 | < 0.001 | 0.002 | 0.630 |
GATA3 | 11/11 | 0/16 | 0/9 | < 0.001 | < 0.001 | 1.000 |
PAX8 | 11/11 | 15/16 | 4/9 | 1.000 | 0.008 | 0.012 |
CD117 | 0/11 | 0/16 | 0/9 | 1.000 | 1.000 | 1.000 |
TFE3 | 0/11 | 1/16 | 0/9 | 1.000 | 1.000 | 1.000 |
ALK | 0/11 | 0/16 | 0/9 | 1.000 | 1.000 | 1.000 |
Ki67 (%) | 1 ~ 3 | 2 ~ 15 | 2 ~ 20 |